Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
To determine if ZD6474 a new investigational drug, is effective in treating Non Small Lung
Cancer and if so, how it compares with another type of anti cancer therapy chemotherapy,
Erlotinib